Michael Scolaro

Michael Scolaro

Aug 27, 2017

Group 6 Copy 48
0
    Please wait...

    About This Project

    We hypothesize that targeted delivery of Curcumin to antigen presenting cells in the immune system can suppress tumor growth for a variety of cancers. This study will examine tumor responses to Curcumin in a colon cancer mouse model when given alone or in combination with an FDA-approved immune Checkpoint Inhibitor. Positive results will lead to Fast-Track FDA applications for human and companion pet animal cancer trials.

    Blast off!

    Browse Other Projects on Experiment

    Related Projects

    How do chemical exposures trigger autoimmune diseases?

    The cause of onset of autoimmune disease is poorly understood, but may be linked to exposure to certain...

    Are current antibacterial treatments resulting in the evolution of more virulent multidrug resistant bacteria?

    Each year in the U.S. 23,000 people die as a direct result of antibiotic resistant infections. I hypothesize...

    How does Sprint Training Impact Blood Sugar and Inflammation?

    Exercise intensity has a huge effect on how endurance training, like running, effects health. While research...

    Backer Badge Funded